Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Ranibizumab and Bromfenac for Wet AMD
NCT00805233Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Dec 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bromfenac sodium in neovascular age-related macular degeneration (NVAMD), sponsored by Oregon Health & Science University. Started Dec 2008; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT00805233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805233.